These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 6990991

  • 1. Effects of nicotinic acid therapy on high-density lipoprotein metabolism in type II and type IV hyperlipoproteinaemia.
    Packard CJ, Stewart JM, Third JL, Morgan HG, Lawrie TD, Shepherd J.
    Biochim Biophys Acta; 1980 Apr 18; 618(1):53-62. PubMed ID: 6990991
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T, Nakai T, Yamada S, Kobayashi T, Hayashi T, Kutsumi Y, Takeda R.
    Artery; 1979 Feb 18; 5(2):125-43. PubMed ID: 231951
    [Abstract] [Full Text] [Related]

  • 4. [Sulfinpyrazone and lipoproteins: absence of effects on serum lipids in hyperlipoproteinemias of types II and IV].
    Sommariva D, Scotti L, Baroni L, Beggi P, Fasoli A.
    Clin Ter; 1980 Mar 31; 92(6):649-55. PubMed ID: 7460493
    [No Abstract] [Full Text] [Related]

  • 5. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W, Reuter W.
    Z Gesamte Inn Med; 1982 Dec 15; 37(24):830-3. PubMed ID: 6963524
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV].
    Bednarska-Makaruk M, Kuźmińska A, Chotkowska E, Kurjata P, Polakowska M, Broda G, Rywik S.
    Pol Arch Med Wewn; 1992 Mar 15; 87(3):149-56. PubMed ID: 1523145
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)].
    Loeper J, Goy-Loeper J, Rouffy J.
    Clin Chim Acta; 1979 Oct 15; 98(1-2):19-26. PubMed ID: 227624
    [Abstract] [Full Text] [Related]

  • 10. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H, Bojanovski D.
    Artery; 1980 Oct 15; 8(2):171-8. PubMed ID: 7458684
    [Abstract] [Full Text] [Related]

  • 11. [Apolipoproteins - an important diagnostic indicator in the evaluation of coronary disease risk].
    Naruszewicz M, Nowicka G.
    Pol Arch Med Wewn; 1980 Aug 15; 64(2):161-6. PubMed ID: 7433154
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of bezafibrate therapy on serum and lipoprotein lipids].
    Romics L, Németh Csóka M, Szám I, Pados G, Karádi I, Köszegi G, Kusztos R.
    Orv Hetil; 1986 Oct 05; 127(40):2425-8, 2431. PubMed ID: 3537905
    [No Abstract] [Full Text] [Related]

  • 14. Fenofibrate therapy of hypertriglyceridaemia. Differential effects on LDL cholesterol level in type IV and in type IIb primary hyperlipoproteinaemia.
    Sommariva D, Bonfiglioli D, Pogliaghi I, Ottomano C, Fasoli A.
    Eur J Clin Pharmacol; 1984 Oct 05; 26(6):741-4. PubMed ID: 6489413
    [Abstract] [Full Text] [Related]

  • 15. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
    Hutt V, Klör HU, Wechsler JG, Ditschuneit H.
    J Clin Chem Clin Biochem; 1984 Feb 05; 22(2):141-6. PubMed ID: 6716054
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Feb 05; 33(5):776-9. PubMed ID: 6683558
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.